🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Rein Therapeutics Inc. (RNTX)
NASDAQ: RNTX · Real-Time Price · USD
0.3553
-0.0011 (-0.31%)
Nov 18, 2026, 4:00 PM EST - Market closed

Rein Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
0.943.2212.8717.315.193.6
Short-Term Investments
34.55---16.0542.33
Cash & Short-Term Investments
35.493.2212.8717.3121.2445.93
Cash Growth
776.80%-75.01%-25.69%-18.50%-53.75%232.73%
Prepaid Expenses
1.29---0.612.22
Restricted Cash
---0.030.030.03
Other Current Assets
-1.110.790.93--
Total Current Assets
36.794.3313.6618.2721.8748.18
Property, Plant & Equipment
--00.020.110.28
Goodwill
6.336.336.336.33--
Other Intangible Assets
13.513.542.279.2--
Long-Term Deferred Charges
---2.14--
Other Long-Term Assets
1.82000.050.020.02
Total Assets
59.4324.1662.19106.0122.0148.48

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
3.23.980.911.191.721.21
Accrued Expenses
2.42.114.722.941.453.15
Current Portion of Leases
---0.050.030.09
Other Current Liabilities
-0.10.120.210.180.06
Total Current Liabilities
5.66.185.754.393.384.51
Long-Term Leases
-----0.07
Long-Term Deferred Tax Liabilities
1.061.061.773.33--
Other Long-Term Liabilities
--0.28---
Total Liabilities
6.667.247.87.713.384.58

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.170.110.110.090.090.09
Additional Paid-In Capital
426.73373.13360.7295.38291.37289.28
Retained Earnings
-419.02-401.27-351.4-288.52-272.79-245.46
Comprehensive Income & Other
-0.12-0.06-0.02-0.06-0.05-0.01
Total Common Equity
7.77-28.099.396.8918.6243.9
Shareholders' Equity
52.7716.9254.3998.318.6243.9
Total Liabilities & Equity
59.4324.1662.19106.0122.0148.48

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
---0.050.030.16
Net Cash (Debt)
35.493.2212.8717.2721.2145.77
Net Cash Growth
776.80%-75.01%-25.49%-18.60%-53.66%241.12%
Net Cash Per Share
0.660.130.723.754.6710.31
Filing Date Shares Outstanding
86.2728.0421.9916.974.544.53
Total Common Shares Outstanding
86.2727.5521.674.894.544.53
Working Capital
31.19-1.857.9113.8818.4943.67
Book Value Per Share
0.09-1.020.431.414.109.69
Tangible Book Value
-12.06-47.92-39.14-78.6418.6243.9
Tangible Book Value Per Share
-0.14-1.74-1.81-16.104.109.69
Machinery
----0.340.34
SEC Filings: 10-K · 10-Q